CovidSeniorV1, Main, Exploration, bibRecord, 000413

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.

Identifieur interne : 000413 ( Main/Exploration ); précédent : 000412; suivant : 000414

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.

Auteurs : Rebecca Hasseli [Allemagne] ; Ulf Mueller-Ladner [Allemagne] ; Tim Schmeiser [Allemagne] ; Bimba F. Hoyer [Allemagne] ; Andreas Krause [Allemagne] ; Hanns-Martin Lorenz [Allemagne] ; Anne Constanze Regierer [Allemagne] ; Jutta G. Richter [Allemagne] ; Anja Strangfeld [Allemagne] ; Reinhard E. Voll [Allemagne] ; Alexander Pfeil [Allemagne] ; Hendrik Schulze-Koops [Allemagne] ; Christof Specker [Allemagne]

Source :

RMD open [ 2056-5933 ] ; 2020.

RBID : pubmed:32878994

Descripteurs français

English descriptors

Abstract

OBJECTIVES

Patients with inflammatory rheumatic diseases (IRD) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe course of COVID-19. The influence of immunomodulating drugs on the course of COVID-19 is unknown. To gather knowledge about SARS-CoV-2 infections in patients with IRD, we established a registry shortly after the beginning of the pandemic in Germany.

METHODS

Using an online questionnaire (www.COVID19-rheuma.de), a nationwide database was launched on 30 March 2020, with appropriate ethical and data protection approval to collect data of patients with IRD infected with SARS-CoV-2. In this registry, key clinical and epidemiological parameters-for example, diagnosis of IRD, antirheumatic therapies, comorbidities and course of the infection-are documented.

RESULTS

Until 25 April 2020, data from 104 patients with IRD infected with SARS-CoV-2 were reported (40 males; 63 females; 1 diverse). Most of them (45%) were diagnosed with rheumatoid arthritis, 59% had one or more comorbidities and 42% were treated with biological disease-modifying antirheumatic drugs. Hospitalisation was reported in 32% of the patients. Two-thirds of the patients already recovered. Unfortunately, 6 patients had a fatal course.

CONCLUSIONS

In a short time, a national registry for SARS-CoV2-infected patients with IRD was established. Within 4 weeks, 104 cases were documented. The registry enables to generate data rapidly in this emerging situation and to gain a better understanding of the course of SARS-CoV2-infection in patients with IRD, with a distinct focus on their immunomodulatory therapies. This knowledge is valuable for timely information of physicians and patients with IRD, and shall also serve for the development of guidance for the management of patients with IRD during this pandemic.

DOI: 10.1136/rmdopen-2020-001332
PubMed: 32878994
PubMed Central: PMC7507994

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000374
to stream Main, to step Curation: 000374

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.</title>
<author><name sortKey="Hasseli, Rebecca" sort="Hasseli, Rebecca" uniqKey="Hasseli R" first="Rebecca" last="Hasseli">Rebecca Hasseli</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen, Germany r.hasseli@kerckhoff-klinik.de.</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mueller Ladner, Ulf" sort="Mueller Ladner, Ulf" uniqKey="Mueller Ladner U" first="Ulf" last="Mueller-Ladner">Ulf Mueller-Ladner</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schmeiser, Tim" sort="Schmeiser, Tim" uniqKey="Schmeiser T" first="Tim" last="Schmeiser">Tim Schmeiser</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Immunology, Saint Josef Hospital, Wuppertal, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Immunology, Saint Josef Hospital, Wuppertal</wicri:regionArea>
<wicri:noRegion>Wuppertal</wicri:noRegion>
<wicri:noRegion>Wuppertal</wicri:noRegion>
<wicri:noRegion>Wuppertal</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hoyer, Bimba F" sort="Hoyer, Bimba F" uniqKey="Hoyer B" first="Bimba F" last="Hoyer">Bimba F. Hoyer</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel</wicri:regionArea>
<placeName><region type="land" nuts="2">Schleswig-Holstein</region>
<settlement type="city">Kiel</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krause, Andreas" sort="Krause, Andreas" uniqKey="Krause A" first="Andreas" last="Krause">Andreas Krause</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital Berlin, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital Berlin, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lorenz, Hanns Martin" sort="Lorenz, Hanns Martin" uniqKey="Lorenz H" first="Hanns-Martin" last="Lorenz">Hanns-Martin Lorenz</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, University of Heidelberg, Heidelberg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology, University of Heidelberg, Heidelberg</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Regierer, Anne Constanze" sort="Regierer, Anne Constanze" uniqKey="Regierer A" first="Anne Constanze" last="Regierer">Anne Constanze Regierer</name>
<affiliation wicri:level="3"><nlm:affiliation>Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Epidemiology Unit, German Rheumatism Research Centre, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Richter, Jutta G" sort="Richter, Jutta G" uniqKey="Richter J" first="Jutta G" last="Richter">Jutta G. Richter</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Hiller Research Unit, Heinrich-Heine-University, Medical Faculty, Duesseldorf, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Hiller Research Unit, Heinrich-Heine-University, Medical Faculty, Duesseldorf</wicri:regionArea>
<wicri:noRegion>Duesseldorf</wicri:noRegion>
<wicri:noRegion>Duesseldorf</wicri:noRegion>
<wicri:noRegion>Duesseldorf</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Strangfeld, Anja" sort="Strangfeld, Anja" uniqKey="Strangfeld A" first="Anja" last="Strangfeld">Anja Strangfeld</name>
<affiliation wicri:level="3"><nlm:affiliation>Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Epidemiology Unit, German Rheumatism Research Centre, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Voll, Reinhard E" sort="Voll, Reinhard E" uniqKey="Voll R" first="Reinhard E" last="Voll">Reinhard E. Voll</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center, Faculty of Medicine, Albert-Ludwigs University of Freiburg, Freiburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, University Medical Center, Faculty of Medicine, Albert-Ludwigs University of Freiburg, Freiburg</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Fribourg-en-Brisgau</region>
<settlement type="city">Fribourg-en-Brisgau</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfeil, Alexander" sort="Pfeil, Alexander" uniqKey="Pfeil A" first="Alexander" last="Pfeil">Alexander Pfeil</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine III, University Hospital Jena, Jena, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Internal Medicine III, University Hospital Jena, Jena</wicri:regionArea>
<wicri:noRegion>Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schulze Koops, Hendrik" sort="Schulze Koops, Hendrik" uniqKey="Schulze Koops H" first="Hendrik" last="Schulze-Koops">Hendrik Schulze-Koops</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author><name sortKey="Specker, Christof" sort="Specker, Christof" uniqKey="Specker C" first="Christof" last="Specker">Christof Specker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, KEM Kliniken Essen-Mitte,Essen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, KEM Kliniken Essen-Mitte,Essen</wicri:regionArea>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32878994</idno>
<idno type="pmid">32878994</idno>
<idno type="doi">10.1136/rmdopen-2020-001332</idno>
<idno type="pmc">PMC7507994</idno>
<idno type="wicri:Area/Main/Corpus">000374</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000374</idno>
<idno type="wicri:Area/Main/Curation">000374</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000374</idno>
<idno type="wicri:Area/Main/Exploration">000374</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.</title>
<author><name sortKey="Hasseli, Rebecca" sort="Hasseli, Rebecca" uniqKey="Hasseli R" first="Rebecca" last="Hasseli">Rebecca Hasseli</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen, Germany r.hasseli@kerckhoff-klinik.de.</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mueller Ladner, Ulf" sort="Mueller Ladner, Ulf" uniqKey="Mueller Ladner U" first="Ulf" last="Mueller-Ladner">Ulf Mueller-Ladner</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schmeiser, Tim" sort="Schmeiser, Tim" uniqKey="Schmeiser T" first="Tim" last="Schmeiser">Tim Schmeiser</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Immunology, Saint Josef Hospital, Wuppertal, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Immunology, Saint Josef Hospital, Wuppertal</wicri:regionArea>
<wicri:noRegion>Wuppertal</wicri:noRegion>
<wicri:noRegion>Wuppertal</wicri:noRegion>
<wicri:noRegion>Wuppertal</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hoyer, Bimba F" sort="Hoyer, Bimba F" uniqKey="Hoyer B" first="Bimba F" last="Hoyer">Bimba F. Hoyer</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel</wicri:regionArea>
<placeName><region type="land" nuts="2">Schleswig-Holstein</region>
<settlement type="city">Kiel</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krause, Andreas" sort="Krause, Andreas" uniqKey="Krause A" first="Andreas" last="Krause">Andreas Krause</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital Berlin, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital Berlin, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lorenz, Hanns Martin" sort="Lorenz, Hanns Martin" uniqKey="Lorenz H" first="Hanns-Martin" last="Lorenz">Hanns-Martin Lorenz</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, University of Heidelberg, Heidelberg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology, University of Heidelberg, Heidelberg</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Regierer, Anne Constanze" sort="Regierer, Anne Constanze" uniqKey="Regierer A" first="Anne Constanze" last="Regierer">Anne Constanze Regierer</name>
<affiliation wicri:level="3"><nlm:affiliation>Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Epidemiology Unit, German Rheumatism Research Centre, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Richter, Jutta G" sort="Richter, Jutta G" uniqKey="Richter J" first="Jutta G" last="Richter">Jutta G. Richter</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Hiller Research Unit, Heinrich-Heine-University, Medical Faculty, Duesseldorf, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Hiller Research Unit, Heinrich-Heine-University, Medical Faculty, Duesseldorf</wicri:regionArea>
<wicri:noRegion>Duesseldorf</wicri:noRegion>
<wicri:noRegion>Duesseldorf</wicri:noRegion>
<wicri:noRegion>Duesseldorf</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Strangfeld, Anja" sort="Strangfeld, Anja" uniqKey="Strangfeld A" first="Anja" last="Strangfeld">Anja Strangfeld</name>
<affiliation wicri:level="3"><nlm:affiliation>Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Epidemiology Unit, German Rheumatism Research Centre, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Voll, Reinhard E" sort="Voll, Reinhard E" uniqKey="Voll R" first="Reinhard E" last="Voll">Reinhard E. Voll</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center, Faculty of Medicine, Albert-Ludwigs University of Freiburg, Freiburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, University Medical Center, Faculty of Medicine, Albert-Ludwigs University of Freiburg, Freiburg</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Fribourg-en-Brisgau</region>
<settlement type="city">Fribourg-en-Brisgau</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfeil, Alexander" sort="Pfeil, Alexander" uniqKey="Pfeil A" first="Alexander" last="Pfeil">Alexander Pfeil</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine III, University Hospital Jena, Jena, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Internal Medicine III, University Hospital Jena, Jena</wicri:regionArea>
<wicri:noRegion>Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
<wicri:noRegion>Jena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schulze Koops, Hendrik" sort="Schulze Koops, Hendrik" uniqKey="Schulze Koops H" first="Hendrik" last="Schulze-Koops">Hendrik Schulze-Koops</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author><name sortKey="Specker, Christof" sort="Specker, Christof" uniqKey="Specker C" first="Christof" last="Specker">Christof Specker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, KEM Kliniken Essen-Mitte,Essen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Rheumatology and Clinical Immunology, KEM Kliniken Essen-Mitte,Essen</wicri:regionArea>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">RMD open</title>
<idno type="eISSN">2056-5933</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Arthritis, Psoriatic (complications)</term>
<term>Arthritis, Psoriatic (drug therapy)</term>
<term>Arthritis, Rheumatoid (complications)</term>
<term>Arthritis, Rheumatoid (drug therapy)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Biological Products (therapeutic use)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Female (MeSH)</term>
<term>Germany (MeSH)</term>
<term>Granulomatosis with Polyangiitis (complications)</term>
<term>Granulomatosis with Polyangiitis (drug therapy)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Lupus Erythematosus, Systemic (complications)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Polymyalgia Rheumatica (complications)</term>
<term>Polymyalgia Rheumatica (drug therapy)</term>
<term>Prognosis (MeSH)</term>
<term>Registries (MeSH)</term>
<term>Rheumatic Diseases (complications)</term>
<term>Rheumatic Diseases (drug therapy)</term>
<term>Scleroderma, Systemic (complications)</term>
<term>Scleroderma, Systemic (drug therapy)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Spondylitis, Ankylosing (complications)</term>
<term>Spondylitis, Ankylosing (drug therapy)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Allemagne (MeSH)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Arthrite psoriasique (complications)</term>
<term>Arthrite psoriasique (traitement médicamenteux)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Enregistrements (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Granulomatose avec polyangéite (complications)</term>
<term>Granulomatose avec polyangéite (traitement médicamenteux)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (physiopathologie)</term>
<term>Jeune adulte (MeSH)</term>
<term>Lupus érythémateux disséminé (complications)</term>
<term>Lupus érythémateux disséminé (traitement médicamenteux)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pelvispondylite rhumatismale (complications)</term>
<term>Pelvispondylite rhumatismale (traitement médicamenteux)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (physiopathologie)</term>
<term>Polyarthrite rhumatoïde (complications)</term>
<term>Polyarthrite rhumatoïde (traitement médicamenteux)</term>
<term>Produits biologiques (usage thérapeutique)</term>
<term>Pronostic (MeSH)</term>
<term>Rhumatisme inflammatoire des ceintures (complications)</term>
<term>Rhumatisme inflammatoire des ceintures (traitement médicamenteux)</term>
<term>Rhumatismes (complications)</term>
<term>Rhumatismes (traitement médicamenteux)</term>
<term>Sclérodermie systémique (complications)</term>
<term>Sclérodermie systémique (traitement médicamenteux)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term>
<term>Biological Products</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Arthritis, Psoriatic</term>
<term>Arthritis, Rheumatoid</term>
<term>Coronavirus Infections</term>
<term>Granulomatosis with Polyangiitis</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Pneumonia, Viral</term>
<term>Polymyalgia Rheumatica</term>
<term>Rheumatic Diseases</term>
<term>Scleroderma, Systemic</term>
<term>Spondylitis, Ankylosing</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Psoriatic</term>
<term>Arthritis, Rheumatoid</term>
<term>Granulomatosis with Polyangiitis</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Polymyalgia Rheumatica</term>
<term>Rheumatic Diseases</term>
<term>Scleroderma, Systemic</term>
<term>Spondylitis, Ankylosing</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Arthrite psoriasique</term>
<term>Granulomatose avec polyangéite</term>
<term>Lupus érythémateux disséminé</term>
<term>Pelvispondylite rhumatismale</term>
<term>Polyarthrite rhumatoïde</term>
<term>Rhumatisme inflammatoire des ceintures</term>
<term>Rhumatismes</term>
<term>Sclérodermie systémique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term>
<term>Arthrite psoriasique</term>
<term>Granulomatose avec polyangéite</term>
<term>Infections à coronavirus</term>
<term>Lupus érythémateux disséminé</term>
<term>Pelvispondylite rhumatismale</term>
<term>Pneumopathie virale</term>
<term>Polyarthrite rhumatoïde</term>
<term>Produits biologiques</term>
<term>Rhumatisme inflammatoire des ceintures</term>
<term>Rhumatismes</term>
<term>Sclérodermie systémique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Betacoronavirus</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Prognosis</term>
<term>Registries</term>
<term>Severity of Illness Index</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Betacoronavirus</term>
<term>Enregistrements</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Pronostic</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b>
</p>
<p>Patients with inflammatory rheumatic diseases (IRD) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe course of COVID-19. The influence of immunomodulating drugs on the course of COVID-19 is unknown. To gather knowledge about SARS-CoV-2 infections in patients with IRD, we established a registry shortly after the beginning of the pandemic in Germany.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>Using an online questionnaire (www.COVID19-rheuma.de), a nationwide database was launched on 30 March 2020, with appropriate ethical and data protection approval to collect data of patients with IRD infected with SARS-CoV-2. In this registry, key clinical and epidemiological parameters-for example, diagnosis of IRD, antirheumatic therapies, comorbidities and course of the infection-are documented.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Until 25 April 2020, data from 104 patients with IRD infected with SARS-CoV-2 were reported (40 males; 63 females; 1 diverse). Most of them (45%) were diagnosed with rheumatoid arthritis, 59% had one or more comorbidities and 42% were treated with biological disease-modifying antirheumatic drugs. Hospitalisation was reported in 32% of the patients. Two-thirds of the patients already recovered. Unfortunately, 6 patients had a fatal course.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>In a short time, a national registry for SARS-CoV2-infected patients with IRD was established. Within 4 weeks, 104 cases were documented. The registry enables to generate data rapidly in this emerging situation and to gain a better understanding of the course of SARS-CoV2-infection in patients with IRD, with a distinct focus on their immunomodulatory therapies. This knowledge is valuable for timely information of physicians and patients with IRD, and shall also serve for the development of guidance for the management of patients with IRD during this pandemic.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32878994</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2056-5933</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>6</Volume>
<Issue>2</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>RMD open</Title>
<ISOAbbreviation>RMD Open</ISOAbbreviation>
</Journal>
<ArticleTitle>National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e001332</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/rmdopen-2020-001332</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES">Patients with inflammatory rheumatic diseases (IRD) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe course of COVID-19. The influence of immunomodulating drugs on the course of COVID-19 is unknown. To gather knowledge about SARS-CoV-2 infections in patients with IRD, we established a registry shortly after the beginning of the pandemic in Germany.</AbstractText>
<AbstractText Label="METHODS">Using an online questionnaire (www.COVID19-rheuma.de), a nationwide database was launched on 30 March 2020, with appropriate ethical and data protection approval to collect data of patients with IRD infected with SARS-CoV-2. In this registry, key clinical and epidemiological parameters-for example, diagnosis of IRD, antirheumatic therapies, comorbidities and course of the infection-are documented.</AbstractText>
<AbstractText Label="RESULTS">Until 25 April 2020, data from 104 patients with IRD infected with SARS-CoV-2 were reported (40 males; 63 females; 1 diverse). Most of them (45%) were diagnosed with rheumatoid arthritis, 59% had one or more comorbidities and 42% were treated with biological disease-modifying antirheumatic drugs. Hospitalisation was reported in 32% of the patients. Two-thirds of the patients already recovered. Unfortunately, 6 patients had a fatal course.</AbstractText>
<AbstractText Label="CONCLUSIONS">In a short time, a national registry for SARS-CoV2-infected patients with IRD was established. Within 4 weeks, 104 cases were documented. The registry enables to generate data rapidly in this emerging situation and to gain a better understanding of the course of SARS-CoV2-infection in patients with IRD, with a distinct focus on their immunomodulatory therapies. This knowledge is valuable for timely information of physicians and patients with IRD, and shall also serve for the development of guidance for the management of patients with IRD during this pandemic.</AbstractText>
<CopyrightInformation>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hasseli</LastName>
<ForeName>Rebecca</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0002-2982-8253</Identifier>
<AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen, Germany r.hasseli@kerckhoff-klinik.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Mueller-Ladner</LastName>
<ForeName>Ulf</ForeName>
<Initials>U</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Giessen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Schmeiser</LastName>
<ForeName>Tim</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Saint Josef Hospital, Wuppertal, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hoyer</LastName>
<ForeName>Bimba F</ForeName>
<Initials>BF</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krause</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital Berlin, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lorenz</LastName>
<ForeName>Hanns-Martin</ForeName>
<Initials>HM</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology, University of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Regierer</LastName>
<ForeName>Anne Constanze</ForeName>
<Initials>AC</Initials>
<Identifier Source="ORCID">0000-0003-2456-4049</Identifier>
<AffiliationInfo><Affiliation>Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Richter</LastName>
<ForeName>Jutta G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology and Hiller Research Unit, Heinrich-Heine-University, Medical Faculty, Duesseldorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Strangfeld</LastName>
<ForeName>Anja</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Voll</LastName>
<ForeName>Reinhard E</ForeName>
<Initials>RE</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center, Faculty of Medicine, Albert-Ludwigs University of Freiburg, Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pfeil</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Jena, Jena, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Schulze-Koops</LastName>
<ForeName>Hendrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Specker</LastName>
<ForeName>Christof</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, KEM Kliniken Essen-Mitte,Essen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>RMD Open</MedlineTA>
<NlmUniqueID>101662038</NlmUniqueID>
<ISSNLinking>2056-5933</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001688">Biological Products</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015535" MajorTopicYN="N">Arthritis, Psoriatic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014890" MajorTopicYN="N">Granulomatosis with Polyangiitis</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011111" MajorTopicYN="N">Polymyalgia Rheumatica</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012216" MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012595" MajorTopicYN="N">Scleroderma, Systemic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013167" MajorTopicYN="N">Spondylitis, Ankylosing</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Antirheumatic Agents</Keyword>
<Keyword MajorTopicYN="Y">Autoimmune Diseases</Keyword>
<Keyword MajorTopicYN="Y">Communicable Diseases</Keyword>
<Keyword MajorTopicYN="Y">Epidemiology</Keyword>
<Keyword MajorTopicYN="Y">Health services research</Keyword>
<Keyword MajorTopicYN="Y">Imported</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>07</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>08</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32878994</ArticleId>
<ArticleId IdType="pii">rmdopen-2020-001332</ArticleId>
<ArticleId IdType="doi">10.1136/rmdopen-2020-001332</ArticleId>
<ArticleId IdType="pmc">PMC7507994</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2016 Sep;75(9):1667-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26567181</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>New Microbes New Infect. 2020 Apr 22;35:100684</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32322397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 26;368:m1198</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32217618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):840-842</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32345619</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Care Res (Hoboken). 2013 Jun;65(6):854-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23281295</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Jun 26;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32591357</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Jul;79(7):859-866</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32471903</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jun;55(6):105982</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32305588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Res Ther. 2019 Oct 12;21(1):211</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31604447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microb Pathog. 1995 Sep;19(3):175-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8559046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2020 Jun;95:106-112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32272262</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2008 Sep;173(3):600-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18688037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 May;55(5):105954</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32234467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Postgrad Med J. 2020 Sep;96(1139):550-555</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32295814</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Z Rheumatol. 2020 May;79(4):379-384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32303821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACR Open Rheumatol. 2019 Aug 06;1(7):424-432</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31777822</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 2002 Sep;46(9):2287-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12355475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheumatol. 2020 Apr 29;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32349183</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rheumatology (Oxford). 2019 May 1;58(5):748-764</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29982766</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 2001 Sep;31(9):2566-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11536154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Reumatismo. 2012 Dec 11;64(5):299-306</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23256105</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bade-Wurtemberg</li>
<li>Bavière</li>
<li>Berlin</li>
<li>District de Fribourg-en-Brisgau</li>
<li>District de Haute-Bavière</li>
<li>District de Karlsruhe</li>
<li>Schleswig-Holstein</li>
</region>
<settlement><li>Berlin</li>
<li>Fribourg-en-Brisgau</li>
<li>Heidelberg</li>
<li>Kiel</li>
<li>Munich</li>
</settlement>
<orgName><li>Université Louis-et-Maximilien de Munich</li>
</orgName>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Hasseli, Rebecca" sort="Hasseli, Rebecca" uniqKey="Hasseli R" first="Rebecca" last="Hasseli">Rebecca Hasseli</name>
</noRegion>
<name sortKey="Hoyer, Bimba F" sort="Hoyer, Bimba F" uniqKey="Hoyer B" first="Bimba F" last="Hoyer">Bimba F. Hoyer</name>
<name sortKey="Krause, Andreas" sort="Krause, Andreas" uniqKey="Krause A" first="Andreas" last="Krause">Andreas Krause</name>
<name sortKey="Lorenz, Hanns Martin" sort="Lorenz, Hanns Martin" uniqKey="Lorenz H" first="Hanns-Martin" last="Lorenz">Hanns-Martin Lorenz</name>
<name sortKey="Mueller Ladner, Ulf" sort="Mueller Ladner, Ulf" uniqKey="Mueller Ladner U" first="Ulf" last="Mueller-Ladner">Ulf Mueller-Ladner</name>
<name sortKey="Pfeil, Alexander" sort="Pfeil, Alexander" uniqKey="Pfeil A" first="Alexander" last="Pfeil">Alexander Pfeil</name>
<name sortKey="Regierer, Anne Constanze" sort="Regierer, Anne Constanze" uniqKey="Regierer A" first="Anne Constanze" last="Regierer">Anne Constanze Regierer</name>
<name sortKey="Richter, Jutta G" sort="Richter, Jutta G" uniqKey="Richter J" first="Jutta G" last="Richter">Jutta G. Richter</name>
<name sortKey="Schmeiser, Tim" sort="Schmeiser, Tim" uniqKey="Schmeiser T" first="Tim" last="Schmeiser">Tim Schmeiser</name>
<name sortKey="Schulze Koops, Hendrik" sort="Schulze Koops, Hendrik" uniqKey="Schulze Koops H" first="Hendrik" last="Schulze-Koops">Hendrik Schulze-Koops</name>
<name sortKey="Specker, Christof" sort="Specker, Christof" uniqKey="Specker C" first="Christof" last="Specker">Christof Specker</name>
<name sortKey="Strangfeld, Anja" sort="Strangfeld, Anja" uniqKey="Strangfeld A" first="Anja" last="Strangfeld">Anja Strangfeld</name>
<name sortKey="Voll, Reinhard E" sort="Voll, Reinhard E" uniqKey="Voll R" first="Reinhard E" last="Voll">Reinhard E. Voll</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000413 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000413 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidSeniorV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32878994
   |texte=   National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32878994" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidSeniorV1

This area was generated with Dilib version V0.6.37.
Data generation: Thu Oct 15 09:49:45 2020. Site generation: Wed Jan 27 17:10:23 2021

	Serveur d'exploration sur la COVID chez les séniors
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID chez les séniors

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki